AGC Biologics in the news for our work toward COVID-19 treatment

Seattle CBS affiliate KIRO visited our Bothell, Washington headquarters to interview AGC Biologics CEO Patricio Massera and Chief Business Officer Mark Womack about the work we’re doing with partner CytoDyn. CytoDyn scientists discovered that HIV drug leronlimab could potentially work to treat COVID-19. AGC Biologics is producing a key molecule for the drug.

VIDEO_ Drug used to treat HIV, cancer patients showing promising results for COVID-19 patients


Topics: News
Follow Us
Join us on LinkedIn Follow us on Twitter